Novavax Inc (NVAX)
4.93
+0.22
(+4.67%)
USD |
NASDAQ |
May 03, 16:00
4.90
-0.03
(-0.61%)
Pre-Market: 20:00
Novavax Gross Profit (Quarterly): 98.42M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 98.42M |
September 30, 2023 | -76.86M |
June 30, 2023 | 368.65M |
March 31, 2023 | -40.51M |
December 31, 2022 | 106.06M |
September 30, 2022 | 193.71M |
June 30, 2022 | -85.15M |
March 31, 2022 | 589.47M |
December 31, 2021 | -726.51M |
September 30, 2021 | 178.84M |
June 30, 2021 | 298.02M |
March 31, 2021 | 447.23M |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 4.187M |
June 30, 2014 | 3.157M |
March 31, 2014 | 4.441M |
December 31, 2013 | |
September 30, 2013 | 2.526M |
June 30, 2013 | 1.899M |
March 31, 2013 | 2.121M |
December 31, 2012 | 2.614M |
September 30, 2012 | 1.927M |
June 30, 2012 | 1.985M |
March 31, 2012 | 0.856M |
December 31, 2011 | 2.605M |
September 30, 2011 | 2.818M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-726.51M
Minimum
Dec 2021
589.47M
Maximum
Mar 2022
112.61M
Average
142.45M
Median
Gross Profit (Quarterly) Benchmarks
Pfizer Inc | 11.50B |
Moderna Inc | 71.00M |
Agilent Technologies Inc | 908.00M |
Halozyme Therapeutics Inc | 177.74M |
Vaxart Inc | -- |